CARLSBAD, Calif.--(BUSINESS WIRE)--
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will present
at the 16th Annual Needham Healthcare Conference to be held
at the Westin Grand Central in New York on Wednesday, April 5, 2017. The
presentation will be delivered by Hany
Massarany, President and Chief Executive Officer, and is scheduled
to begin at 10:40 A.M. Eastern Time. The presentation will be made
available at http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
Diagnostics (NASDAQ: GNMK) is a leading provider of automated,
multiplex molecular diagnostic testing systems that detect and measure
DNA and RNA targets to diagnose disease and optimize patient treatment.
Utilizing GenMark's proprietary eSensor® detection technology, GenMark's
eSensor XT-8® system is designed to support a broad range of molecular
diagnostic tests with a compact, easy-to-use workstation and
self-contained, disposable test cartridges. The eSensor detection
technology is also incorporated into GenMark's new sample-to-answer
system ePlex®. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170328006549/en/
GenMark Diagnostics, Inc.
Hany Massarany, 760-448-4325
Chief Executive Officer
Source: GenMark Diagnostics, Inc.
News Provided by Acquire Media